Alan Matsumoto, M.D.
Appointments:
- Part-time Faculty, Division of Rheumatology, Department of Medicine, Johns Hopkins University
Research Interests:
- Therapeutic intervention in rheumatic diseases with particular interest in rheumatoid arthritis
Clinical Interests:
- Rheumatoid Disease
Selected Publications:
- Matsumoto AK, Cavanaugh PF. Etoricoxib. Drugs Today 40(5):395-414, 2004. Review.
- Matsumoto AK. 2004. Arthritis. In RG Miller, BH Ashar, SD Sisson (eds): The Johns Hopkins Internal Medicine Board Review Mosby, Philadelphia, PA.
- Matsumoto, AK 2003. Rheumatoid Arthritis. In LRBarker, JR Burton, PD Zieve, N Fiebach, DE Kern, P Thomas, R Ziegelstein (eds): Principles of Ambulatory Medicine 6th Edition, Lippincott, Williams and Wilkins, Baltimore, MD.
- Bartlett SJ, Piedmont R, Bilderback A, Matsumoto AK, Bathon JM. 2003. Spirituality, Well-being and Quality of Life in People with Rheumatoid Arthritis. Arthritis Rheum 49(6):778-783, 2003.
- Matsumoto AK, Melian A, Mandel DR, et al. 2002: A Randomized, Controlled, Clinical Trial of Etoricoxib in the Treatment of Rheumatoid Arthritis. J Rheumatol 29:1623-30, 2002.
- Bathon JM, Matsumoto AK. 2001. Anti-tumor necrosis factor agents . In Tsokos G, Moreland LM, Martel-Pelletier J, Gay S (eds): Modern Therapeutics in Rheumatic Diseases.
- Moreland LW, Koopman WJ, Admason TC, Calabrese LH, Cash JM, Markeson JA, Matsumoto AK: T cell receptor peptide vaccination in RA: A placebo controlled trial using a combination of Vb3, Vb14, and Vb17 peptides. Arthritis Rheum, 41:1919-29, 1998.
- Matsumoto AK, Martin DR, Carter RH, Ahearn JM, Klickstein LB, Fearon DT: Functional domains mediating the CD21/CD19/TAPA-1/Leu-13 complex on B lymphocytes. J Exp Med 178:1407-1417, 1993.
Education:
- M.D.: University of Illinois at Chicago
- Internship and Residency: UMDNJ-Robert Wood Johnson Medical School
- Post-doctoral Fellowship: The Johns Hopkins University, School of Medicine, Rheumatology
Societies:
- American College of Physicians
- American College of Rheumatology